Resolvin D1 reduces emphysema and chronic inflammation

American Journal of Pathology

Volumn 185, Issue 12, 2015, Pages 3189-3201

  Hsiao, Hsi Min ^a   Thatcher, Thomas H ^a   Colas, Romain A ^b   Serhan, Charles N ^b   Phipps, Richard P ^a   Sime, Patricia J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ASPIRIN TRIGGERED RESOLVIN D1; CIGARETTE SMOKE; LIPID; RESOLVIN D1; UNCLASSIFIED DRUG; DOCOSAHEXAENOIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKE-INDUCED EMPHYSEMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LUNG EMPHYSEMA; MALE; METABOLISM; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOKING; SUPPLEMENTATION; ADULT; ADVERSE EFFECTS; AGED; ANIMAL; C57BL MOUSE; CHRONIC DISEASE; DRUG EFFECTS; LUNG ALVEOLUS MACROPHAGE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PNEUMONIA; PRECLINICAL STUDY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CHRONIC DISEASE; DOCOSAHEXAENOIC ACIDS; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; MACROPHAGES, ALVEOLAR; MALE; MICE, INBRED C57BL; MIDDLE AGED; OXIDATIVE STRESS; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SIGNAL TRANSDUCTION; SMOKING;

EID: 84947795521     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.08.008     Document Type: Article

References (56)

1. T. Yoshida, and R.M. Tuder Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease Physiol Rev 87 2007 1047 1082
2. S. Salvi, and P.J. Barnes Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest 138 2010 3 6
3. P.J. Barnes New therapies for chronic obstructive pulmonary disease Med Princ Pract 19 2010 330 338
4. R.M. Tuder, and I. Petrache Pathogenesis of chronic obstructive pulmonary disease J Clin Invest 122 2012 2749 2755
5. P.J. Barnes Mediators of chronic obstructive pulmonary disease Pharmacol Rev 56 2004 515 548
6. J.C. Hogg, F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, L. Buzatu, R.M. Cherniack, R.M. Rogers, F.C. Sciurba, H.O. Coxson, and P.D. Pare The nature of small-airway obstruction in chronic obstructive pulmonary disease N Engl J Med 350 2004 2645 2653
7. L. Zuo, F. He, G.G. Sergakis, M.S. Koozehchian, J.N. Stimpfl, Y. Rong, P.T. Diaz, and T.M. Best Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments Am J Physiol Lung Cell Mol Physiol 307 2014 L205 L218
8. F. Holguin Oxidative stress in airway diseases. Ann Am Thorac Soc 10 Suppl 2013 S150 S157
9. C.N. Serhan Pro-resolving lipid mediators are leads for resolution physiology Nature 510 2014 92 101
10. E. Shahar, A.R. Folsom, S.L. Melnick, M.S. Tockman, G.W. Comstock, V. Gennaro, M.W. Higgins, P.D. Sorlie, W.J. Ko, M. Szklo Atherosclerosis Risk in Communities Study Investigators Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease N Engl J Med 331 1994 228 233
11. H.M. Hsiao, R.E. Sapinoro, T.H. Thatcher, A. Croasdell, E.P. Levy, R.A. Fulton, K.C. Olsen, S.J. Pollock, C.N. Serhan, R.P. Phipps, and P.J. Sime A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation PLoS One 8 2013 e58258
12. B. Wang, X. Gong, J.Y. Wan, L. Zhang, Z. Zhang, H.Z. Li, and S. Min Resolvin D1 protects mice from LPS-induced acute lung injury Pulm Pharmacol Ther 24 2011 434 441
13. A.P. Rogerio, O. Haworth, R. Croze, S.F. Oh, M. Uddin, T. Carlo, M.A. Pfeffer, R. Priluck, C.N. Serhan, and B.D. Levy Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses J Immunol 189 2012 1983 1991
14. J. Dalli, and C.N. Serhan Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators Blood 120 2012 e60 e72
15. R.A. Colas, M. Shinohara, J. Dalli, N. Chiang, and C.N. Serhan Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue Am J Physiol Cell Physiol 307 2014 C39 C54
16. T.H. Thatcher, S.B. Maggirwar, C.J. Baglole, H.F. Lakatos, T.A. Gasiewicz, R.P. Phipps, and P.J. Sime Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB Am J Pathol 170 2007 855 864
17. H.F. Lakatos, H.A. Burgess, T.H. Thatcher, M.R. Redonnet, E. Hernady, J.P. Williams, and P.J. Sime Oropharyngeal aspiration of a silica suspension produces a superior model of silicosis in the mouse when compared to intratracheal instillation Exp Lung Res 32 2006 181 199
18. M. Kawakami, J.L. Paul, and W.M. Thurlbeck The effect of age on lung structure in male BALB/cNNia inbred mice Am J Anat 170 1984 1 21
19. T. Yoshida, I. Mett, A.K. Bhunia, J. Bowman, M. Perez, L. Zhang, A. Gandjeva, L. Zhen, U. Chukwueke, T. Mao, A. Richter, E. Brown, H. Ashush, N. Notkin, A. Gelfand, R.K. Thimmulappa, T. Rangasamy, T. Sussan, G. Cosgrove, M. Mouded, S.D. Shapiro, I. Petrache, S. Biswal, E. Feinstein, and R.M. Tuder Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema Nat Med 16 2010 767 773
20. C.B. Clish, B.D. Levy, N. Chiang, H.H. Tai, and C.N. Serhan Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation J Biol Chem 275 2000 25372 25380
21. Y.P. Sun, S.F. Oh, J. Uddin, R. Yang, K. Gotlinger, E. Campbell, S.P. Colgan, N.A. Petasis, and C.N. Serhan Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation J Biol Chem 282 2007 9323 9334
22. M. Romano Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins Inflamm Allergy Drug Targets 5 2006 81 90
23. A. Croasdell, T.H. Thatcher, R.M. Kottmann, R.A. Colas, J. Dalli, C.N. Serhan, P.J. Sime, and R.P. Phipps Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages Am J Physiol Lung Cell Mol Physiol 309 2015 L888 L901
24. T.H. March, J.A. Wilder, D.C. Esparza, P.Y. Cossey, L.F. Blair, L.K. Herrera, J.D. McDonald, M.J. Campen, J.L. Mauderly, and J. Seagrave Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice Toxicol Sci 92 2006 545 559
25. R.A. Stockley, D. Mannino, and P.J. Barnes Burden and pathogenesis of chronic obstructive pulmonary disease Proc Am Thorac Soc 6 2009 524 526
26. M. Decramer, W. Janssens, and M. Miravitlles Chronic obstructive pulmonary disease Lancet 379 2012 1341 1351
27. P.J. Barnes Novel approaches and targets for treatment of chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 1999 S72 S79
28. D. Morse, and I.O. Rosas Tobacco smoke-induced lung fibrosis and emphysema Annu Rev Physiol 76 2014 493 513
29. T. Rangasamy, V. Misra, L. Zhen, C.G. Tankersley, R.M. Tuder, and S. Biswal Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression Am J Physiol Lung Cell Mol Physiol 296 2009 L888 L900
30. C.J. Baglole, S.M. Bushinsky, T.M. Garcia, A. Kode, I. Rahman, P.J. Sime, and R.P. Phipps Differential induction of apoptosis by cigarette smoke extract in primary human lung fibroblast strains: implications for emphysema Am J Physiol Lung Cell Mol Physiol 291 2006 L19 L29
31. M. Podowski, C. Calvi, S. Metzger, K. Misono, H. Poonyagariyagorn, A. Lopez-Mercado, T. Ku, T. Lauer, S. McGrath-Morrow, A. Berger, C. Cheadle, R. Tuder, H.C. Dietz, W. Mitzner, R. Wise, and E. Neptune Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice J Clin Invest 122 2012 229 240
32. H. Zeng, X. Kong, H. Peng, Y. Chen, S. Cai, H. Luo, and P. Chen Apoptosis and Bcl-2 family proteins, taken to chronic obstructive pulmonary disease Eur Rev Med Pharmacol Sci 16 2012 711 727
33. I. Rahman, A.A. van Schadewijk, A.J. Crowther, P.S. Hiemstra, J. Stolk, W. MacNee, and W.I. De Boer 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 490 495
34. F.O. Martinez, L. Helming, and S. Gordon Alternative activation of macrophages: an immunologic functional perspective Annu Rev Immunol 27 2009 451 483
35. S. Gordon Alternative activation of macrophages Nat Rev Immunol 3 2003 23 35
36. D. Li, R. Guabiraba, A.G. Besnard, M. Komai-Koma, M.S. Jabir, L. Zhang, G.J. Graham, M. Kurowska-Stolarska, F.Y. Liew, C. McSharry, and D. Xu IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice J Allergy Clin Immunol 134 2014 1422 1432.e11
37. S. Murthy, J.L. Larson-Casey, A.J. Ryan, C. He, L. Kobzik, and A.B. Carter Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure FASEB J 29 2015 3527 3536
38. A. Mantovani, S.K. Biswas, M.R. Galdiero, A. Sica, and M. Locati Macrophage plasticity and polarization in tissue repair and remodelling J Pathol 229 2013 176 185
39. S. Bozinovski, D. Anthony, and R. Vlahos Targeting pro-resolution pathways to combat chronic inflammation in COPD J Thorac Dis 6 2014 1548 1556
40. S. Bozinovski, M. Uddin, R. Vlahos, M. Thompson, J.L. McQualter, A.S. Merritt, P.A. Wark, A. Hutchinson, L.B. Irving, B.D. Levy, and G.P. Anderson Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease Proc Natl Acad Sci U S A 109 2012 935 940
41. P. Kalinski Regulation of immune responses by prostaglandin E2 J Immunol 188 2012 21 28
42. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat Immunol 2 2001 612 619
43. S. Bozinovski, D. Anthony, G.P. Anderson, L.B. Irving, B.D. Levy, and R. Vlahos Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways Pharmacol Ther 140 2013 280 289
44. S.N. Cooray, T. Gobbetti, T. Montero-Melendez, S. McArthur, D. Thompson, A.J. Clark, R.J. Flower, and M. Perretti Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses Proc Natl Acad Sci U S A 110 2013 18232 18237
45. C. Calero, E. Arellano, J.L. Lopez-Villalobos, V. Sanchez-Lopez, N. Moreno-Mata, and J.L. Lopez-Campos Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patients BMC Pulm Med 14 2014 95
46. L. Balode, G. Strazda, N. Jurka, U. Kopeika, A. Kislina, M. Bukovskis, M. Beinare, V. Gardjusina, and I. Taivans Lipoxygenase-derived arachidonic acid metabolites in chronic obstructive pulmonary disease Medicina 48 2012 292 298
47. S. Takanashi, Y. Hasegawa, Y. Kanehira, K. Yamamoto, K. Fujimoto, K. Satoh, and K. Okamura Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers Eur Respir J 14 1999 309 314
48. A. Recchiuti, S. Krishnamoorthy, G. Fredman, N. Chiang, and C.N. Serhan MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits FASEB J 25 2011 544 560
49. H.M. Hsiao, T.H. Thatcher, E.P. Levy, R.A. Fulton, K.M. Owens, R.P. Phipps, and P.J. Sime Resolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1 J Immunol 193 2014 4980 4987
50. H. Seki, K. Fukunaga, M. Arita, H. Arai, H. Nakanishi, R. Taguchi, T. Miyasho, R. Takamiya, K. Asano, A. Ishizaka, J. Takeda, and B.D. Levy The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury J Immunol 184 2010 836 843
51. L. Li, Y. Wu, Y. Wang, J. Wu, L. Song, W. Xian, S. Yuan, L. Pei, and Y. Shang Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells J Neuroinflammation 11 2014 72
52. M. Spite, L. Summers, T.F. Porter, S. Srivastava, A. Bhatnagar, and C.N. Serhan Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress Br J Pharmacol 158 2009 1062 1073
53. T.W. Jung, H.J. Hwang, H.C. Hong, H.Y. Choi, H.J. Yoo, S.H. Baik, and K.M. Choi Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells Mol Cell Endocrinol 391 2014 30 40
54. H.N. Lee, and Y.J. Surh Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis Biochem Pharmacol 86 2013 759 769
55. J.M. Schwab, N. Chiang, M. Arita, and C.N. Serhan Resolvin E1 and protectin D1 activate inflammation-resolution programmes Nature 447 2007 869 874
56. P.J. Barnes New anti-inflammatory targets for chronic obstructive pulmonary disease Nat Rev Drug Discov 12 2013 543 559